Endosurgery in treatment of urinary bladder cancer in elderly patients

Alferov S.M.; Grishin M.A.; Emel'ianenko A.V.

doi:https://doi.org/

Alferov S.M.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Grishin M.A.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Emel'ianenko A.V.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Endosurgery in treatment of urinary bladder cancer in elderly patients

Authors:

Alferov S.M., Grishin M.A., Emel'ianenko A.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2010;(9): 30‑35

Read: 2159 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Alferov SM, Grishin MA, Emel'ianenko AV. Endosurgery in treatment of urinary bladder cancer in elderly patients. Pirogov Russian Journal of Surgery. 2010;(9):30‑35. (In Russ.)

Подписка 2026 Хирургия. Журнал им. Н.И. Пирогова (Pirogov Russian Journal of Surgery)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

The first experience of using an autograft from the wide fascia of the thigh for closing oroantral fistula. Stomatology. 2025;(1):17-22

Endoscopic removal of gangliocytic paraganglioma of the major duodenal papilla. Endoscopic Surgery. 2025;(2):43-49

The role of minimally invasive transpapillary surgical interventions in emergency abdominal surgery. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):12-18

Abstract:

Treatment of 162 patients with micro- and macrohematuria was analyzed. Urinary bladder cancer was diagnosed in 156 of them (men - 127, women - 29). All patients received endoscopic treatment (transurethral resection). An average age of patients was 74,4±7,9 years. 142 (91,1%) of patients were older then 60 years. The transitional cell carcinoma was diagnosed in 118 patients. The urinary bladder cancer recurrence was diagnosed in 13 (9,2%) patients steged T1 and in 24 (16,9%) staged T2. Only 2 patients with T3 stage of the disease were considered to be unsuitable for endoscopic transurethral resection and received an open argon tumor vaporization.

Keywords:

urinary bladder cancer

endoscopic transurethral resection

Authors:

Alferov S.M.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Grishin M.A.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Emel'ianenko A.V.

Tsentral'naia klinicheskaia bol'nitsa Upravleniia delami Prezidenta RF, Moskva

Close metadata

References:

Aksel' E.M. Zabolevaemost' zlokachestvennymi novoobrazovaniyami mochevykh i muzhskikh polovykh organov v Rossii v 2003 g. Onkourologiya 2005; 1: 6-9.
Statistika zlokachestvennykh novoobrazovanii v Rossii i stranakh SNG v 2004 g. Pod red. akad. RAN i RAMN M.I. Davydova i d.m.n. E.M. Aksel'. M: Vestn Ros onkol tsentra im. N.N. Blokhina.
Karyakin O.B. Neoad''yuvantnaya i ad''yuvantnaya terapiya pri organosokhranyayushchem lechenii raka mochevogo puzyrya. VI Rossiiskaya onkologicheskaya konferentsiya 26-28 noyabrya 2002 g. Moskva.
Loran O.B., Pushkar' D.Yu., Rasner P.I. Lechenie poverkhnostnogo raka mochevogo puzyrya vo II-III stadiyakh zabolevaniya. V Rossiiskaya onkologicheskaya konferentsiya 27-29 noyabrya 2001 g. Moskva.
Martov A.G., Sysoev P.A., Gushchin B.L., Kozlov V.V. Tselesoobrazny li konservativnye operatsii pri invazivnom rake mochevogo puzyrya? VI Rossiiskaya onkologicheskaya konferentsiya 26-28 noyabrya 2002 g. Moskva.
Matveev B.P., Figurin K.M., Karyakin O.B. Rak mochevogo puzyrya. M 2001.
Amiel G.E., Shu T., Lerner S.P. Alternatives to cytology in the management of non-nuiscle invasive bladder cancer. Curr Treat Options Oncol 2004; 5: 5: 377-389.
Goffin J.R, Rajan R., Souhami L. Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer. Am J Clin Oncol 2004; 27: 2: 172-177.
Grossman H.B., Messing E., Soloway M. et al. Detection of bladder cancer using a point-of-care proteomic assay. JAMA 2005; 16: 293: 7: 810-816.
Hautmann S., Toma M., Lorenzo Gomes M.F. et al. Immunocyt and the HA-Haase urine test for the detection of bladder cancer: a side-by-side comparison. Eur Urol 2004; 46: 4: 466-471.
Hollenbeck B.K., Miller D.C., Taub D. et al. Aggressive treatment for bladder cancer is associated with improved overall survival among patients 80 years old or older. Urology 2004; 64: 2: 292-297.
Hussian S.A., James N.D. Organ preservation strategies in bladder cancer. Expert Rev Anticancer Ther 2002; 2: 6: 641-651.
Kageyama S., Jsono T., Iwaki H. et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem 2004; 50: 5: 857-860.
Kageyama S., Isono T., Iwaki H. et al. Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine. Clin Chem 2004; 50: 5: 861-866.
Kim H.E., Steinberg G.D. The current status of bladder preservation iri the treatment of muscle invasive bladder cancer. J Urol 2000; 164: (3 Pt 1): 627-632.
Kuczyk M., Turkeri L. et al. Is there a role for bladder strategies in the treatment of muscle-invasive bladder cancer? Eur Urol 2003; 44: l: 557-564.
Mariappan P., Smith G. A surveillance schedule for GITa bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database. J Urol 2005; 173: 4: 1108-1111.
Massod S., Sriprasad S., Palmer J.H. et al. T1G3 bladder cancer - indications for early cystectomy. Hit Urol Kephrol 2004; 36: 1: 41-44.
Otto T., Rubben H. Prevention of bladder cancer. Urologe A 2004; 43: 5: 562-564.
Planz B., Jochims E., Deix T. et al. The role of urinary cytology for detection of bladder cancer. Eur Surg Oncol 2005; 31: 3: 304-308.
Saga Y., Numata A., Tokumutsi M. et al. Comparative study of novel endoluminal ultrasonography and conventional transurethral ultrasonography in staging of bladder cancer. Int J Urol 2004; 11: 8: 597-601.
Schoeder G.L., Lorenzo-Gomez M.F., Hautmann S.H. et al. A side-by-side comparison of cytology and biomarkers for bladder cancer detection. J Urol 2004; 172: 3: 1123-1126.
Shipley W.U., Kaufman D.S. et al. Overview of bladder cancer trials in the Radiation therapy Oncology Group. Cancer 2003; 15: 97 (8 Suppl): 2115-2119.
Szabo I., Nyirady P. Asymptomatic bladder cancer evaluated by gynecological sonography. Orv Hetil 2005; 27: 146: 9: 425-427.
Theodorescu D. Molecular pathogenesis of urothelial bladder cancer. Histol Uistopatol 2003; 18: 259-274.
Toma M.I., Friedench M.G., Hautmann S.H. et al. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer. World J Urol 2004; 22: 2: 145-149. Epub 2004; 27.
Torres-Roca J.F. Bladder preservation protocols in the treatment of muscle-invasive bladder cancer. Cancer Control 2004; 11: 6: 358-363.